Quarterly Result30 Oct 2026, 04:21 pm
Indo Us Bio-Tech Declares Unaudited Q2 FY27 Results
AI Summary
Indo Us Bio-Tech Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results along with the limited review reports from the auditor. The Board meeting took place on October 30, 2026.
Key Highlights
- Unaudited financial results for Q2 FY27 declared.
- Half-year ended September 30, 2026 results also approved.
- Limited review reports from the auditor were obtained.
- Board meeting held on October 30, 2026.
- Results prepared in accordance with Ind-AS 34.
Price Impact
More from INDOUS